We are back again to take look at the cannabis industry’s top performers for the week. Out of over 200 publicly listed cannabis companies, these four companies rose over 5% on the week and have market capitalizations of $30 million USD or more. This week's 4 biggest marijuana stock winners are:

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Earlier in the week, the company announced positive phase 2 trial results for its drug aiming to treat "rare, chronic, serious inflammatory and fibrotic diseases." While you may be wondering what this company was doing on our radar, the drug candidate interacts with the body’s endocannabinoid system. This news helped the pharmaceutical company see a share price increase from $6.95 at the open on Monday morning to $7.78 Friday at the close. This gain represents an increase of almost 12% on the week.

MGC Pharmaceuticals Limited (ASX:MXC) (OTC:MGCLF)

MGC Pharmaceuticals is an Australian medical marijuana company. Shares of MGC Pharmaceuticals Ltd. (ASX:MXC) (OTC:MGCLF) skyrocketed on news of a highly lucrative supply contract with a Korean cosmetics manufacturer. This deal is expected to generate approximately $40 MM AUD in annual revenue for MGC’s MGC Derma division. Shares of the company on the OTC markets opened up the week at $0.03 per share, and ended the week at $0.064 per share, amounting to a weekly gain of over 107%.

OWC Pharmaceutical Research Corp. (OTC:OWCP)

OWC Pharmaceutical Research Corp. is focused on discovering, developing and commercializing cannabis-based novel therapeutics products and treatments. The stock performed particularly poorly last week, but this week took the chance to recover. Monday at the open shares were trading at $0.35, and closed Friday at $0.3755.This change represents an increase of over 7.25% on the week.

Zelda Therapeutics Limited (ASX:ZLD) (OTC:ZLDAF)

Zelda Therapeutics is an Australian biotechnology company focused on cannabinoid-based therapies for numerous conditions. Late last month, Zelda Therapeutics reported that their sponsored observational trial delivered successful results in treating symptoms of autism. Without any news this week, the Australian company saw a noticeable jump in price per share. Their OTC listing was trading at $0.06 at the open on Monday, and by Friday, closed at $0.0656 USD. This increase in share price represents an increase of over 9.5% on the week.

The Daily Marijuana Observer is a leading source for cannabis-related investment news and more. Our mission is to destigmatize capital flow into the cannabis sector by providing investors with a trusted resource for research and exploration.

Want to learn how to invest?

Get a free 10 week email series that will teach you how to start investing.

Delivered twice a week, straight to your inbox.